Android app on Google Play

Cantor Fitzgerald Starts Sucampo Pharmaceuticals (SCMP) at Buy

April 3, 2013 7:24 AM EDT Send to a Friend
Get Alerts SCMP Hot Sheet
Price: $6.17 -1.28%

Rating Summary:
    2 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 38 | New: 6
Trade SCMP Now!
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Sucampo Pharmaceuticals (NASDAQ: SCMP) with a Buy rating and a price target of $9.00. Analysts said the company's key product Amitiza has near-term catalysts, as it awaits an FDA decision in late April on label expansion. The time to play Amitiza is now, said analyst Adeyemi Ogunkoya.

For an analyst ratings summary and ratings history on Sucampo Pharmaceuticals click here. For more ratings news on Sucampo Pharmaceuticals click here.

Shares of Sucampo Pharmaceuticals closed at $6.33 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment